The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiparasitic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Antiparasitic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antiparasitic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Antiparasitic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While by Type segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Antiparasitic Drugs include Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, and GlaxoSmithKline Plc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antiparasitic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Antiparasitic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Antiparasitic Drugs, with revenue, gross margin and global market share of Antiparasitic Drugs from 2019 to 2022.
Chapter 3, the Antiparasitic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Antiparasitic Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Antiparasitic Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
The Antiparasitic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antiparasitic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Antiparasitic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While by Type segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Antiparasitic Drugs include Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, and GlaxoSmithKline Plc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antiparasitic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Antiparasitic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Antiparasitic Drugs, with revenue, gross margin and global market share of Antiparasitic Drugs from 2019 to 2022.
Chapter 3, the Antiparasitic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Antiparasitic Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Antiparasitic Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Antiparasitic Drugs
1.2 Classification of Antiparasitic Drugs by Type
1.2.1 Overview: Global Antiparasitic Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Antiparasitic Drugs Revenue Market Share by Type in 2021
1.2.3 Anthelmintics
1.2.4 Antiprotozoals
1.2.5 Others
1.3 Global Antiparasitic Drugs Market by Application
1.3.1 Overview: Global Antiparasitic Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Antiparasitic Drugs Market Size & Forecast
1.5 Global Antiparasitic Drugs Market Size and Forecast by Region
1.5.1 Global Antiparasitic Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Antiparasitic Drugs Market Size by Region, (2017-2022)
1.5.3 North America Antiparasitic Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Antiparasitic Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Antiparasitic Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Antiparasitic Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Antiparasitic Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiparasitic Drugs Market Drivers
1.6.2 Antiparasitic Drugs Market Restraints
1.6.3 Antiparasitic Drugs Trends Analysis
2 Company Profiles
2.1 Ipca Laboratories Ltd
2.1.1 Ipca Laboratories Ltd Details
2.1.2 Ipca Laboratories Ltd Major Business
2.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Product and Solutions
2.1.4 Ipca Laboratories Ltd Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Ipca Laboratories Ltd Recent Developments and Future Plans
2.2 Zydus Cadila
2.2.1 Zydus Cadila Details
2.2.2 Zydus Cadila Major Business
2.2.3 Zydus Cadila Antiparasitic Drugs Product and Solutions
2.2.4 Zydus Cadila Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Zydus Cadila Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antiparasitic Drugs Product and Solutions
2.3.4 Merck Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Merck Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Antiparasitic Drugs Product and Solutions
2.4.4 Pfizer Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 GlaxoSmithKline Plc.
2.5.1 GlaxoSmithKline Plc. Details
2.5.2 GlaxoSmithKline Plc. Major Business
2.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Product and Solutions
2.5.4 GlaxoSmithKline Plc. Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKline Plc. Recent Developments and Future Plans
2.6 Cipla Ltd
2.6.1 Cipla Ltd Details
2.6.2 Cipla Ltd Major Business
2.6.3 Cipla Ltd Antiparasitic Drugs Product and Solutions
2.6.4 Cipla Ltd Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Cipla Ltd Recent Developments and Future Plans
2.7 Ranbaxy Laboratories
2.7.1 Ranbaxy Laboratories Details
2.7.2 Ranbaxy Laboratories Major Business
2.7.3 Ranbaxy Laboratories Antiparasitic Drugs Product and Solutions
2.7.4 Ranbaxy Laboratories Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Ranbaxy Laboratories Recent Developments and Future Plans
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Antiparasitic Drugs Product and Solutions
2.8.4 Novartis AG Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Novartis AG Recent Developments and Future Plans
2.9 Alvizia Health Care
2.9.1 Alvizia Health Care Details
2.9.2 Alvizia Health Care Major Business
2.9.3 Alvizia Health Care Antiparasitic Drugs Product and Solutions
2.9.4 Alvizia Health Care Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Alvizia Health Care Recent Developments and Future Plans
2.10 Bayer AG
2.10.1 Bayer AG Details
2.10.2 Bayer AG Major Business
2.10.3 Bayer AG Antiparasitic Drugs Product and Solutions
2.10.4 Bayer AG Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bayer AG Recent Developments and Future Plans
2.11 Roche Inc
2.11.1 Roche Inc Details
2.11.2 Roche Inc Major Business
2.11.3 Roche Inc Antiparasitic Drugs Product and Solutions
2.11.4 Roche Inc Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Roche Inc Recent Developments and Future Plans
2.12 Arbor Pharmaceuticals Inc.
2.12.1 Arbor Pharmaceuticals Inc. Details
2.12.2 Arbor Pharmaceuticals Inc. Major Business
2.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product and Solutions
2.12.4 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Arbor Pharmaceuticals Inc. Recent Developments and Future Plans
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Antiparasitic Drugs Product and Solutions
2.13.4 Sanofi Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Sanofi Recent Developments and Future Plans
2.14 AstraZeneca
2.14.1 AstraZeneca Details
2.14.2 AstraZeneca Major Business
2.14.3 AstraZeneca Antiparasitic Drugs Product and Solutions
2.14.4 AstraZeneca Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 AstraZeneca Recent Developments and Future Plans
2.15 Alkem Laboratories Limited
2.15.1 Alkem Laboratories Limited Details
2.15.2 Alkem Laboratories Limited Major Business
2.15.3 Alkem Laboratories Limited Antiparasitic Drugs Product and Solutions
2.15.4 Alkem Laboratories Limited Antiparasitic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Alkem Laboratories Limited Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antiparasitic Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Antiparasitic Drugs Players Market Share in 2021
3.2.2 Top 10 Antiparasitic Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Antiparasitic Drugs Players Head Office, Products and Services Provided
3.4 Antiparasitic Drugs Mergers & Acquisitions
3.5 Antiparasitic Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antiparasitic Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Antiparasitic Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Antiparasitic Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Antiparasitic Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Antiparasitic Drugs Revenue by Type (2017-2028)
6.2 North America Antiparasitic Drugs Revenue by Application (2017-2028)
6.3 North America Antiparasitic Drugs Market Size by Country
6.3.1 North America Antiparasitic Drugs Revenue by Country (2017-2028)
6.3.2 United States Antiparasitic Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Antiparasitic Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Antiparasitic Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Antiparasitic Drugs Revenue by Type (2017-2028)
7.2 Europe Antiparasitic Drugs Revenue by Application (2017-2028)
7.3 Europe Antiparasitic Drugs Market Size by Country
7.3.1 Europe Antiparasitic Drugs Revenue by Country (2017-2028)
7.3.2 Germany Antiparasitic Drugs Market Size and Forecast (2017-2028)
7.3.3 France Antiparasitic Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Antiparasitic Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Antiparasitic Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Antiparasitic Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antiparasitic Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Antiparasitic Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Antiparasitic Drugs Market Size by Region
8.3.1 Asia-Pacific Antiparasitic Drugs Revenue by Region (2017-2028)
8.3.2 China Antiparasitic Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Antiparasitic Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Antiparasitic Drugs Market Size and Forecast (2017-2028)
8.3.5 India Antiparasitic Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Antiparasitic Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Antiparasitic Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Antiparasitic Drugs Revenue by Type (2017-2028)
9.2 South America Antiparasitic Drugs Revenue by Application (2017-2028)
9.3 South America Antiparasitic Drugs Market Size by Country
9.3.1 South America Antiparasitic Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Antiparasitic Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Antiparasitic Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antiparasitic Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Antiparasitic Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Antiparasitic Drugs Market Size by Country
10.3.1 Middle East & Africa Antiparasitic Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Antiparasitic Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Antiparasitic Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Antiparasitic Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Antiparasitic Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Antiparasitic Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Antiparasitic Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Antiparasitic Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Antiparasitic Drugs Revenue Market Share by Region (2023-2028)
Table 6. Ipca Laboratories Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Ipca Laboratories Ltd Major Business
Table 8. Ipca Laboratories Ltd Antiparasitic Drugs Product and Solutions
Table 9. Ipca Laboratories Ltd Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 11. Zydus Cadila Major Business
Table 12. Zydus Cadila Antiparasitic Drugs Product and Solutions
Table 13. Zydus Cadila Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Antiparasitic Drugs Product and Solutions
Table 17. Merck Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Antiparasitic Drugs Product and Solutions
Table 21. Pfizer Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKline Plc. Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Plc. Major Business
Table 24. GlaxoSmithKline Plc. Antiparasitic Drugs Product and Solutions
Table 25. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Cipla Ltd Corporate Information, Head Office, and Major Competitors
Table 27. Cipla Ltd Major Business
Table 28. Cipla Ltd Antiparasitic Drugs Product and Solutions
Table 29. Cipla Ltd Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Ranbaxy Laboratories Corporate Information, Head Office, and Major Competitors
Table 31. Ranbaxy Laboratories Major Business
Table 32. Ranbaxy Laboratories Antiparasitic Drugs Product and Solutions
Table 33. Ranbaxy Laboratories Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 35. Novartis AG Major Business
Table 36. Novartis AG Antiparasitic Drugs Product and Solutions
Table 37. Novartis AG Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Alvizia Health Care Corporate Information, Head Office, and Major Competitors
Table 39. Alvizia Health Care Major Business
Table 40. Alvizia Health Care Antiparasitic Drugs Product and Solutions
Table 41. Alvizia Health Care Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 43. Bayer AG Major Business
Table 44. Bayer AG Antiparasitic Drugs Product and Solutions
Table 45. Bayer AG Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Roche Inc Corporate Information, Head Office, and Major Competitors
Table 47. Roche Inc Major Business
Table 48. Roche Inc Antiparasitic Drugs Product and Solutions
Table 49. Roche Inc Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Arbor Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Arbor Pharmaceuticals Inc. Major Business
Table 52. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product and Solutions
Table 53. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Sanofi Corporate Information, Head Office, and Major Competitors
Table 55. Sanofi Major Business
Table 56. Sanofi Antiparasitic Drugs Product and Solutions
Table 57. Sanofi Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 59. AstraZeneca Major Business
Table 60. AstraZeneca Antiparasitic Drugs Product and Solutions
Table 61. AstraZeneca Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Alkem Laboratories Limited Corporate Information, Head Office, and Major Competitors
Table 63. Alkem Laboratories Limited Major Business
Table 64. Alkem Laboratories Limited Antiparasitic Drugs Product and Solutions
Table 65. Alkem Laboratories Limited Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Antiparasitic Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Antiparasitic Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Antiparasitic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Antiparasitic Drugs Players Head Office, Products and Services Provided
Table 70. Antiparasitic Drugs Mergers & Acquisitions in the Past Five Years
Table 71. Antiparasitic Drugs New Entrants and Expansion Plans
Table 72. Global Antiparasitic Drugs Revenue (USD Million) by Type (2017-2022)
Table 73. Global Antiparasitic Drugs Revenue Share by Type (2017-2022)
Table 74. Global Antiparasitic Drugs Revenue Forecast by Type (2023-2028)
Table 75. Global Antiparasitic Drugs Revenue by Application (2017-2022)
Table 76. Global Antiparasitic Drugs Revenue Forecast by Application (2023-2028)
Table 77. North America Antiparasitic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Antiparasitic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Antiparasitic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Antiparasitic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Antiparasitic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Antiparasitic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Antiparasitic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Antiparasitic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Antiparasitic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Antiparasitic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Antiparasitic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Antiparasitic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Antiparasitic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Antiparasitic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Antiparasitic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Antiparasitic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Antiparasitic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Antiparasitic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Antiparasitic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Antiparasitic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Antiparasitic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Antiparasitic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Antiparasitic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Antiparasitic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Antiparasitic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Antiparasitic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Antiparasitic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Antiparasitic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Antiparasitic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Antiparasitic Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Antiparasitic Drugs Picture
Figure 2. Global Antiparasitic Drugs Revenue Market Share by Type in 2021
Figure 3. Anthelmintics
Figure 4. Antiprotozoals
Figure 5. Others
Figure 6. Antiparasitic Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Others Picture
Figure 10. Global Antiparasitic Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Antiparasitic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Antiparasitic Drugs Revenue Market Share by Region (2017-2028)
Figure 13. Global Antiparasitic Drugs Revenue Market Share by Region in 2021
Figure 14. North America Antiparasitic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Antiparasitic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Antiparasitic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Antiparasitic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Antiparasitic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Antiparasitic Drugs Market Drivers
Figure 20. Antiparasitic Drugs Market Restraints
Figure 21. Antiparasitic Drugs Market Trends
Figure 22. Ipca Laboratories Ltd Recent Developments and Future Plans
Figure 23. Zydus Cadila Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Plc. Recent Developments and Future Plans
Figure 27. Cipla Ltd Recent Developments and Future Plans
Figure 28. Ranbaxy Laboratories Recent Developments and Future Plans
Figure 29. Novartis AG Recent Developments and Future Plans
Figure 30. Alvizia Health Care Recent Developments and Future Plans
Figure 31. Bayer AG Recent Developments and Future Plans
Figure 32. Roche Inc Recent Developments and Future Plans
Figure 33. Arbor Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 34. Sanofi Recent Developments and Future Plans
Figure 35. AstraZeneca Recent Developments and Future Plans
Figure 36. Alkem Laboratories Limited Recent Developments and Future Plans
Figure 37. Global Antiparasitic Drugs Revenue Share by Players in 2021
Figure 38. Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Antiparasitic Drugs Revenue Market Share in 2021
Figure 40. Global Top 10 Players Antiparasitic Drugs Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Antiparasitic Drugs Revenue Share by Type in 2021
Figure 43. Global Antiparasitic Drugs Market Share Forecast by Type (2023-2028)
Figure 44. Global Antiparasitic Drugs Revenue Share by Application in 2021
Figure 45. Global Antiparasitic Drugs Market Share Forecast by Application (2023-2028)
Figure 46. North America Antiparasitic Drugs Sales Market Share by Type (2017-2028)
Figure 47. North America Antiparasitic Drugs Sales Market Share by Application (2017-2028)
Figure 48. North America Antiparasitic Drugs Revenue Market Share by Country (2017-2028)
Figure 49. United States Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Antiparasitic Drugs Sales Market Share by Type (2017-2028)
Figure 53. Europe Antiparasitic Drugs Sales Market Share by Application (2017-2028)
Figure 54. Europe Antiparasitic Drugs Revenue Market Share by Country (2017-2028)
Figure 55. Germany Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Antiparasitic Drugs Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Antiparasitic Drugs Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Antiparasitic Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Antiparasitic Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Antiparasitic Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Antiparasitic Drugs Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Antiparasitic Drugs Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Antiparasitic Drugs Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Antiparasitic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
